Depression has become a common illness among individuals of every age group. Among numerous factors held responsible for depression stress is most vital. Behind the specified disorder various hypothesis has been laid out where Nitric Oxide is emerging target to treat stress induced depression. Antidepressant potential of piperine in stressed and unstressed condition was evaluated using tail suspension test and forced swim test whereas locomotor activity was evaluated by actophotometer. Results of the present study indicate the potential of antidepressant effect of piperine in stress. Methylene blue potentiated the effect of sub- effective dose of PP and SB-203580 enhanced effect of Piperine in stressed mice with no array on locomotor activi...
A B S T R A C T Introduction: Mercury is the second most metal pollutant in the world and has the po...
Depression is associated with significant functional disabilities. Application of new drugs which co...
N-methyl-D-aspartate receptor (NMDA-R) antagonists and nitric oxide inhibitors have shown promising ...
164-170L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) is an important signaling ...
Objectives: Previous studies have suggested antidepressant properties for modafinil; however, the un...
Background: Depression is one of the most common mental illnesses worldwide. Nitric oxide (NO) is in...
Lithium is still the main agent in the management of mood disorders such as depression. Likewise, ag...
Background: Considering the pivotal role of nitric oxide (NO) pathway in depressive disorders, the a...
Dual action antidepressants have important therapeutic implications. Methylene blue (MB), a charged ...
The effects of microinjection of the nitric oxide (NO) precursor L-arginine (L-Arg), the NO synthase...
Objective: We investigated whether the nitric oxide (NO) precursor, L-arginine, can prevent the ant...
Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2005.Depressive disorder...
Recent evidence has suggested that systemic administration of non-selective NOS inhibitors induces a...
Nitric oxide (NO) is an atypical neurotransmitter that has been related to the pathophysiology of ma...
It is now well-established that orexins (OXs) and their receptors are involved in the pathophysiolog...
A B S T R A C T Introduction: Mercury is the second most metal pollutant in the world and has the po...
Depression is associated with significant functional disabilities. Application of new drugs which co...
N-methyl-D-aspartate receptor (NMDA-R) antagonists and nitric oxide inhibitors have shown promising ...
164-170L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) is an important signaling ...
Objectives: Previous studies have suggested antidepressant properties for modafinil; however, the un...
Background: Depression is one of the most common mental illnesses worldwide. Nitric oxide (NO) is in...
Lithium is still the main agent in the management of mood disorders such as depression. Likewise, ag...
Background: Considering the pivotal role of nitric oxide (NO) pathway in depressive disorders, the a...
Dual action antidepressants have important therapeutic implications. Methylene blue (MB), a charged ...
The effects of microinjection of the nitric oxide (NO) precursor L-arginine (L-Arg), the NO synthase...
Objective: We investigated whether the nitric oxide (NO) precursor, L-arginine, can prevent the ant...
Thesis (M.Sc. (Pharmacology))--North-West University, Potchefstroom Campus, 2005.Depressive disorder...
Recent evidence has suggested that systemic administration of non-selective NOS inhibitors induces a...
Nitric oxide (NO) is an atypical neurotransmitter that has been related to the pathophysiology of ma...
It is now well-established that orexins (OXs) and their receptors are involved in the pathophysiolog...
A B S T R A C T Introduction: Mercury is the second most metal pollutant in the world and has the po...
Depression is associated with significant functional disabilities. Application of new drugs which co...
N-methyl-D-aspartate receptor (NMDA-R) antagonists and nitric oxide inhibitors have shown promising ...